Live Quote · NASDAQADAPHealthcare· Biotechnology

Adaptimmune Therapeutics plc

$0.05▼ 3.00%($-0.00)
MKT CAP $75.16MLAST EARNINGS Nov 12, 2025
50%
Bullish
TickerSpark Score
76/100
▌ Solid
84
Valuation
80
Profitability
100
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADAP research report →

Analyst Price Target
$2.83+5735.1% vs. today

Range $1 – $4

Analyst RatingBuy
9 Buy4 Hold3 Sell

Price Chart

-92.69% · this period
$0.83$0.44$0.04Oct 25Apr 30Oct 28
52-Week Range3% of range
Low
$0.02
Current
$0.05
High
$0.86